Cinctive Capital Management LP Ultragenyx Pharmaceutical Inc. Transaction History

Cinctive Capital Management LP

$1.78 Billion
Q2 2025

A detailed history of Cinctive Capital Management LP transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Cinctive Capital Management LP holds 18,731 shares of RARE stock, worth $644,346. This represents 0.04% of its overall portfolio holdings.

Number of Shares

18,731

Previous 77,261 75.76%

Holding current value

$644,346

Previous $2.8 Million 75.65%

% of portfolio

0.04%

Previous 0.23%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$31.06 - $39.3 $1.82 Million - $2.3 Million	-58,530 Reduced 75.76%	18,731 $681,000
Q1 2025 May 15, 2025	BUY	$36.21 - $45.78 $517,839 - $654,699	14,301 Added 22.71%	77,261 $2.8 Million
Q4 2024 Feb 12, 2025	BUY	$42.07 - $57.72 $1.98 Million - $2.72 Million	47,058 Added 295.93%	62,960 $2.65 Million
Q3 2024 Nov 14, 2024	SELL	$40.21 - $59.36 $4.45 Million - $6.58 Million	-110,779 Reduced 87.45%	15,902 $883,000
Q2 2024 Aug 14, 2024	BUY	$37.42 - $51.61 $558,680 - $770,537	14,930 Added 13.36%	126,681 $5.21 Million
Q1 2024 May 15, 2024	BUY	$43.02 - $53.69 $589,374 - $735,553	13,700 Added 13.97%	111,751 $5.22 Million
Q4 2023 Feb 14, 2024	BUY	$31.73 - $49.19 $3.11 Million - $4.82 Million	98,051 New	98,051 $4.69 Million
Q2 2022 Aug 15, 2022	SELL	$45.8 - $85.4 $4.11 Million - $7.66 Million	-89,692 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$62.2 - $84.4 $991,219 - $1.34 Million	15,936 Added 21.61%	89,692 $6.51 Million
Q4 2021 Feb 14, 2022	BUY	$73.71 - $87.86 $1.1 Million - $1.31 Million	14,927 Added 25.37%	73,756 $6.2 Million
Q3 2021 Nov 15, 2021	BUY	$77.92 - $102.4 $2.35 Million - $3.08 Million	30,118 Added 104.9%	58,829 $5.31 Million
Q2 2021 Aug 16, 2021	BUY	$92.19 - $115.71 $1.27 Million - $1.59 Million	13,756 Added 91.98%	28,711 $2.74 Million
Q1 2021 May 17, 2021	BUY	$106.9 - $167.73 $962,955 - $1.51 Million	9,008 Added 151.47%	14,955 $1.7 Million
Q4 2020 Feb 16, 2021	SELL	$84.4 - $177.39 $2.37 Million - $4.99 Million	-28,102 Reduced 82.53%	5,947 $823,000
Q3 2020 Nov 16, 2020	SELL	$72.98 - $90.0 $296,225 - $365,310	-4,059 Reduced 10.65%	34,049 $2.8 Million
Q2 2020 Aug 14, 2020	SELL	$46.91 - $78.22 $1.03 Million - $1.71 Million	-21,925 Reduced 36.52%	38,108 $2.98 Million
Q1 2020 May 15, 2020	SELL	$33.8 - $62.9 $2.49 Million - $4.63 Million	-73,568 Reduced 55.07%	60,033 $2.67 Million
Q4 2019 Feb 14, 2020	BUY	$36.08 - $45.83 $4.82 Million - $6.12 Million	133,601 New	133,601 $5.71 Million

Others Institutions Holding RARE

# of Institutions

362

Shares Held

88.3M

Call Options Held

3.64M

Put Options Held

2.24M

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $2.41B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cinctive Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Cinctive Capital Management LP with notifications on news.

Account

Cinctive Capital Management LP Ultragenyx Pharmaceutical Inc. Transaction History